93 results on '"Le Bourhis, L."'
Search Results
2. 1274 Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis
- Author
-
Hashemi, G., primary, Le Bourhis, L. Sormani, additional, Dight, J., additional, Zhou, C., additional, Roy, E., additional, and Khosrotehrani, K., additional
- Published
- 2023
- Full Text
- View/download PDF
3. DOP084 Peripheral T cell repertoire reconstitution in Crohnʼs disease patients undergoing autologous HSCT
- Author
-
Corraliza, A.M., Masamunt, M.C., Ricart, E., Lpez-García, A., Le Bourhis, L., Allez, M., Panés, J., and Salas, A.
- Published
- 2017
- Full Text
- View/download PDF
4. OP004 Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohnʼs disease
- Author
-
Le Bourhis, L., Corraliza, A., Auzolle, C., Ricart, E., Hawkey, C., Lindsay, J.O., Clark, M., Rogler, G., Satsangui, J., Haller, D., Panes, J., Salas, A., and Allez, M.
- Published
- 2017
- Full Text
- View/download PDF
5. P540 Longitudinal Dynamics of Gut Microbiome and Metabolome After Biological Therapy in Inflammatory Bowel Diseases
- Author
-
Ahmed, M, primary, Metwaly, A, additional, Hammoudi, N, additional, Meng, C, additional, Köhler, N, additional, Le Bourhis, L, additional, Pauling, J, additional, Kleigrewe, K, additional, Allez, M, additional, and Haller, D, additional
- Published
- 2022
- Full Text
- View/download PDF
6. DOP47 Identification and characterization of T-cell receptor sequences associated with Crohn’s Disease
- Author
-
Pesesky, M, primary, Carty, C L, additional, Singh, N, additional, Le Bourhis, L, additional, Rosati, E, additional, Bokemeyer, B, additional, Schreiber, S, additional, Görg, S, additional, Gittelman, R M, additional, Dines, J N, additional, Kaplan, I M, additional, Zahid, H J, additional, Baldo, L, additional, Snyder, T M, additional, Robins, H S, additional, Franke, A, additional, and Allez, M, additional
- Published
- 2022
- Full Text
- View/download PDF
7. DOP33 Role of adherent and invasive E. coli in Crohn’s Disease: Lessons from the postoperative recurrence model
- Author
-
Buisson, A, primary, Sokol, H, additional, Hammoudi, N, additional, Nancey, S, additional, Treton, X, additional, Nachury, M, additional, Fumery, M, additional, Hébuterne, X, additional, Rodrigues, M, additional, Hugot, J P, additional, Boschetti, G, additional, Stefanescu, C, additional, Wils, P, additional, Seksik, P, additional, Le Bourhis, L, additional, Bezault, M, additional, Sauvanet, P, additional, Pereira, B, additional, Allez, M, additional, and Barnich, N, additional
- Published
- 2022
- Full Text
- View/download PDF
8. P031 Intestinal lymphoepithelial interactions in Crohn’s disease: modeling alphaE-beta7 and NKG2D blockade
- Author
-
Hammoudi, N, primary, Hamoudi, S, additional, Bonnereau, J, additional, Bottois, H, additional, Perez, K, additional, Bezault, M, additional, Hassid, D, additional, Chardiny, V, additional, Celine, G, additional, Gergaud, B, additional, Bonnet, J, additional, Chedouba, L, additional, Tran Minh, M L, additional, Gornet, J M, additional, Baudry, C, additional, Corte, H, additional, Maggiori, L, additional, Toubert, A, additional, McBride, J, additional, Brochier, C, additional, Neighbors, M, additional, Le Bourhis, L, additional, and Allez, M, additional
- Published
- 2022
- Full Text
- View/download PDF
9. P059 Diet controls segmented filamentous bacteria in driving Crohn’s disease-like inflammation in TNFdeltaARE mice
- Author
-
Metwaly, A, primary, Calasan, J, additional, Waldschmitt, N, additional, Khaloian, S, additional, Häcker, D, additional, Ahmed, M, additional, Butto, L F, additional, Hammoudi, N, additional, Le Bourhis, L, additional, Mayorgas, A, additional, Siebert, K, additional, Basic, M, additional, Zeissig, S, additional, Schwerd, T, additional, Allez, M, additional, Panes, J, additional, Salas, A, additional, Bleich, A, additional, Cominelli, F, additional, and Haller, D, additional
- Published
- 2022
- Full Text
- View/download PDF
10. 696 Interleukin 6 signalling in endovascular progenitors is a driver of melanoma vascularisation and metastasis
- Author
-
Dight, J.W., primary, Hashemi, G., additional, Wong, H., additional, Sim, S., additional, Sormani Le Bourhis, L., additional, Patel, J., additional, and Khosrotehrani, K., additional
- Published
- 2021
- Full Text
- View/download PDF
11. 538 Sox9 knockout in the endothelium decreases melanoma tumour vascularisation, metastasis, and alters melanoma gene expression
- Author
-
Hashemi, G., primary, Dight, J.W., additional, Sormani Le Bourhis, L., additional, and Khosrotehrani, K., additional
- Published
- 2021
- Full Text
- View/download PDF
12. Long-term outcomes after ileocolonic resection in Crohn's disease according to the severity of early endoscopic recurrence
- Author
-
Fumery, Mathurin, Le Bourhis, L., Nancey, S., Allez, M., Grp, Remind Study, Hammoudi, N., Auzolle, C., Minh, M. L. Tran, Boschetti, G., Bezault, M., Buisson, A., Pariente, B., Treton, X., Seksik, P., CHU Amiens-Picardie, Périnatalité et Risques Toxiques - UMR INERIS_I 1 (PERITOX), Institut National de l'Environnement Industriel et des Risques (INERIS)-Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Hôpital Saint-Louis, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille), Department of Gastroenterology, Centre Hospitalier Général Cannes, Theraptosis S.A., CHU Clermont-Ferrand, Hôpital Claude Huriez [Lille], CHU Lille, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Saint-Antoine [AP-HP], and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
- Subjects
[SDV]Life Sciences [q-bio] ,ComputingMilieux_MISCELLANEOUS - Abstract
International audience
- Published
- 2020
13. OP04 Long-term outcomes after ileocolonic resection in Crohn’s disease according to the severity of early endoscopic recurrence
- Author
-
Hammoudi, N, primary, Auzolle, C, additional, Tran Minh, M L, additional, Boschetti, G, additional, Bezault, M, additional, Buisson, A, additional, Pariente, B, additional, Treton, X, additional, Seksik, P, additional, Fumery, M, additional, Le Bourhis, L, additional, Nancey, S, additional, and Allez, M, additional
- Published
- 2020
- Full Text
- View/download PDF
14. DOP35 Monitoring of mucosal T cells subsets under biotherapies in IBD: responders exhibit a phenotype similar to healthy controls
- Author
-
Hammoudi, N, primary, Perez, K, additional, Hassid, D, additional, Tran Minh, M L, additional, Gornet, J M, additional, Baudry, C, additional, Lourenco, N, additional, Gergaud, B, additional, Chardiny, V, additional, Bonnet, J, additional, Le Bourhis, L, additional, and Allez, M, additional
- Published
- 2020
- Full Text
- View/download PDF
15. 525 Identification of a new gene involved in human skin pigmentation: CLEC12B
- Author
-
Sormani Le Bourhis, L., primary, Taquin, H., additional, Mhaidly, R., additional, Heim, M., additional, Tulic, M., additional, Montaudie, H., additional, Rocchi, S., additional, and Passeron, T., additional
- Published
- 2019
- Full Text
- View/download PDF
16. 442 CLEC12B a new gene implicated in melanoma
- Author
-
Montaudié, H., primary, Sormani Le Bourhis, L., additional, Dadone-Montaudié, B., additional, Beranger, G., additional, Cheli, Y., additional, Petit, V., additional, Rocchi, S., additional, Gesbert, F., additional, Larue, L., additional, and Passeron, T., additional
- Published
- 2019
- Full Text
- View/download PDF
17. Oral tolerance is inefficient in neonatal mice due to a physiological vitamin A deficiency
- Author
-
Turfkruyer, M, primary, Rekima, A, additional, Macchiaverni, P, additional, Le Bourhis, L, additional, Muncan, V, additional, van den Brink, G R, additional, Tulic, M K, additional, and Verhasselt, V, additional
- Published
- 2016
- Full Text
- View/download PDF
18. Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells
- Author
-
Camus, M, primary, Esses, S, additional, Pariente, B, additional, Le Bourhis, L, additional, Douay, C, additional, Chardiny, V, additional, Mocan, I, additional, Benlagha, K, additional, Clave, E, additional, Toubert, A, additional, Mayer, L, additional, and Allez, M, additional
- Published
- 2014
- Full Text
- View/download PDF
19. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells.
- Author
-
Tien, M.-T., primary, Girardin, S. E., additional, Regnault, B., additional, Le Bourhis, L., additional, Dillies, M.-A., additional, Coppée, J.-Y., additional, Bourdet-Sicard, R., additional, Sansonetti, P. J., additional, and Pédron, T., additional
- Published
- 2006
- Full Text
- View/download PDF
20. Increased incidence of ischemic stroke in young: A population-based stroke registry study from 2008 to 2018
- Author
-
Retho, E., Tasseng, Y., Consigny, M., Le Bourhis, L., Leblanc, A., Jourdain, A., Merrien, F.M., Rouhart, F., Viakhireva-Dovganyuk, I., Goas, P., Lavenant, C., Bruguet, M., and Timsit, S.
- Abstract
•In the population-based Brest Stroke Registry, ischemic stroke incidence increased over a 10-year studied period, in young adults under 60-year-old.•Intracerebral hemorrhage incidence decreased in young adults during the same period.•Under 60 most ischemic stroke were minor strokes.•Diagnostic work-up improved across time although ischemic stroke mechanisms remained stable.•Vascular traditional risk factors remained stable across time in patients under 60-year-old.•For stroke mechanisms subtype, in young adults under 60-year-old, while cryptogenic strokes predominate, SSS-TOAST classification reduced the rate of cryptogenic strokes.
- Published
- 2023
- Full Text
- View/download PDF
21. An efficient host/co-processor solution for MPEG-4 audio composition
- Author
-
Le Bourhis, L., primary, Zoia, G., additional, Mattavelli, M., additional, and Mlynek, D.J., additional
- Published
- 1999
- Full Text
- View/download PDF
22. GRAY SCALE OPTICALLY ADDRESSED SPATIAL LIGHT MODULATOR USING TWISTED FERROELECTRIC LIQUID CRYSTALS
- Author
-
Le Bourhis, L., primary, Angele, J., additional, and Dupont, L., additional
- Published
- 1996
- Full Text
- View/download PDF
23. Erratum: Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells (Journal of Immunology (2006) 176 (1228-1237))
- Author
-
Tien, M. -T, Girardin, S. E., Beatrice REGNAULT, Le Bourhis, L., Dillies, M. -A, Coppée, J. -Y, Bourdet-Sicard, R., Sansonetti, P. J., and Pédron, T.
24. Nod2-dependent Th2 polarization of antigen-specific immunity
- Author
-
Magalhaes, J. G., Fritz, J. H., Le Bourhis, L., Sellge, G., Leonardo Travassos, Selvanantham, T., Girardin, S. E., Gommerman, J. L., and Philpott, D. J.
25. T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence
- Author
-
Allez, M, primary, Auzolle, C, additional, Ngollo, M, additional, Bottois, H, additional, Chardiny, V, additional, Corraliza, AM, additional, Salas, A, additional, Perez, K, additional, Stefanescu, C, additional, Nancey, S, additional, Buisson, A, additional, Pariente, B, additional, Fumery, M, additional, Sokol, H, additional, Tréton, X, additional, Barnich, N, additional, Seksik, P, additional, and Le Bourhis, L, additional
- Full Text
- View/download PDF
26. An efficient host/co-processor solution for MPEG-4 audio composition.
- Author
-
Le Bourhis, L., Zoia, G., Mattavelli, M., and Mlynek, D.J.
- Published
- 1999
- Full Text
- View/download PDF
27. Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition.
- Author
-
Bonnereau J, Courau T, Asesio N, Salfati D, Bouhidel F, Corte H, Hamoudi S, Hammoudi N, Lavolé J, Vivier-Chicoteau J, Chardiny V, Maggiori L, Blery M, Remark R, Bonnafous C, Cattan P, Toubert A, Bhat P, Allez M, Aparicio T, and Le Bourhis L
- Subjects
- Humans, Programmed Cell Death 1 Receptor metabolism, Prospective Studies, Intestines pathology, T-Lymphocytes, Colorectal Neoplasms pathology
- Abstract
Objective: T cells are major effectors of the antitumoural immune response. Their activation by tumour-associated antigens can unleash their proliferation and cytotoxic functions, leading to tumour cell elimination. However, tumour-related immunosuppressive mechanisms including the overexpression of immune checkpoints like programmed cell death protein-1 (PD-1), are also engaged, promoting immune escape. Current immunotherapies targeting these pathways have demonstrated weak efficacy in colorectal cancer (CRC). It is thus crucial to find new targets for immunotherapy in this cancer type., Design: In a prospective cohort of patients with CRC, we investigated the phenotype of tumour-related and non-tumour related intestinal T cells (n=44), particularly the adenosinergic pathway, correlating with clinical phenotype. An autologous coculture model was developed between patient-derived primary tumour spheroids and their autologous tumour-associated lymphocytes. We used this relevant model to assess the effects of CD39 blockade on the antitumour T cell response., Results: We show the increased expression of CD39, and its co-expression with PD-1, on tumour infiltrating T cells compared with mucosal lymphocytes. CD39 expression was higher in the right colon and early-stage tumours, thus defining a subset of patients potentially responsive to CD39 blockade. Finally, we demonstrate in autologous conditions that CD39 blockade triggers T cell infiltration and tumour spheroid destruction in cocultures., Conclusion: In CRC, CD39 is strongly expressed on tumour infiltrating lymphocytes and its inhibition represents a promising therapeutic strategy for treating patients., Competing Interests: Competing interests: MA received grant supports from Innate Pharma, Janssen, Takeda and Genentech/Roche; and honorarium from teaching activities or consultancy from AbbVie, Amgen, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Ferring, Genentech, Gilead, IQVIA, Janssen, Novartis, Pfizer, Roche, Takeda, Tillots. TA presented conferences for Shire, Ipsen, Amgen, BMS, Servier, Pfizer, Roche Sanofi and meeting grants for Ipsen, Novartis, Roche and Hospira. He also obtained research grant from Novartis and Innate Pharma. MB, RR and CB were/are Innate Pharma employees., (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
28. Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn's disease.
- Author
-
Metwaly A, Jovic J, Waldschmitt N, Khaloian S, Heimes H, Häcker D, Ahmed M, Hammoudi N, Le Bourhis L, Mayorgas A, Siebert K, Basic M, Schwerd T, Allez M, Panes J, Salas A, Bleich A, Zeissig S, Schnupf P, Cominelli F, and Haller D
- Subjects
- Adult, Humans, Mice, Animals, Child, Inflammation, Diet, Bacteria genetics, Disease Models, Animal, Crohn Disease microbiology, Ileitis microbiology, Ileitis pathology
- Abstract
Background: Crohn's disease (CD) is associated with changes in the microbiota, and murine models of CD-like ileo-colonic inflammation depend on the presence of microbial triggers. Increased abundance of unknown Clostridiales and the microscopic detection of filamentous structures close to the epithelium of Tnf
ΔARE mice, a mouse model of CD-like ileitis pointed towards segmented filamentous bacteria (SFB), a commensal mucosal adherent bacterium involved in ileal inflammation., Results: We show that the abundance of SFB strongly correlates with the severity of CD-like ileal inflammation in two mouse models of ileal inflammation, including TnfΔARE and SAMP/Yit mice. SFB mono-colonization of germ-free TnfΔARE mice confirmed the causal link and resulted in severe ileo-colonic inflammation, characterized by elevated tissue levels of Tnf and Il-17A, neutrophil infiltration and loss of Paneth and goblet cell function. Co-colonization of SFB in human-microbiota associated TnfΔARE mice confirmed that SFB presence is indispensable for disease development. Screening of 468 ileal and colonic mucosal biopsies from adult and pediatric IBD patients, using previously published and newly designed human SFB-specific primer sets, showed no presence of SFB in human tissue samples, suggesting a species-specific functionality of the pathobiont. Simulating the human relevant therapeutic effect of exclusive enteral nutrition (EEN), EEN-like purified diet antagonized SFB colonization and prevented disease development in TnfΔARE mice, providing functional evidence for the protective mechanism of diet in modulating microbiota-dependent inflammation in IBD., Conclusions: We identified a novel pathogenic role of SFB in driving severe CD-like ileo-colonic inflammation characterized by loss of Paneth and goblet cell functions in TnfΔARE mice. A purified diet antagonized SFB colonization and prevented disease development in TnfΔARE mice in contrast to a fiber-containing chow diet, clearly demonstrating the important role of diet in modulating a novel IBD-relevant pathobiont and supporting a direct link between diet and microbial communities in mediating protective functions. Video Abstract., (© 2023. The Author(s).)- Published
- 2023
- Full Text
- View/download PDF
29. Role of adherent and invasive Escherichia coli in Crohn's disease: lessons from the postoperative recurrence model.
- Author
-
Buisson A, Sokol H, Hammoudi N, Nancey S, Treton X, Nachury M, Fumery M, Hébuterne X, Rodrigues M, Hugot JP, Boschetti G, Stefanescu C, Wils P, Seksik P, Le Bourhis L, Bezault M, Sauvanet P, Pereira B, Allez M, and Barnich N
- Subjects
- Humans, Bacterial Adhesion, Colonoscopy, Escherichia coli, Ileum microbiology, Prospective Studies, Recurrence, Crohn Disease pathology, Escherichia coli Infections epidemiology
- Abstract
Objective: We used the postoperative recurrence model to better understand the role of adherent and invasive Escherichia coli (AIEC) bacteria in Crohn's disease (CD), taking advantage of a well-characterised postoperative cohort., Design: From a prospective, multicentre cohort of operated patients with CD, AIEC identification was performed within the surgical specimen (M0) (N=181 patients) and the neoterminal ileum (n=119 patients/181) during colonoscopy performed 6 months after surgery (M6). Endoscopic postoperative recurrence was graded using Rutgeerts' index. The mucosa-associated microbiota was analysed by 16S sequencing at M0 and M6. Relative risks or ORs were adjusted on potential confounders., Results: AIEC prevalence was twofold higher within the neoterminal ileum at M6 (30.3%) than within the surgical specimen (14.9%) (p<0.001). AIEC within the neoterminal ileum at M6 was associated with higher rate of early ileal lesions (i1) (41.6% vs 17.1%; aRR 3.49 (95% CI 1.01 to 12.04), p=0.048) or ileal lesions (i2b+i3) (38.2% vs 17.1%; aRR 3.45 (95% CI 1.06 to 11.30), p=0.040) compared with no lesion (i0). AIEC within the surgical specimen was predictive of higher risk of i2b-endoscopic postoperative recurrence (POR) (aOR 2.54 (95% CI 1.01 to 6.44), p=0.049) and severe endoscopic POR (aOR 3.36 (95% CI 1.25 to 9.06), p=0.017). While only 5.0% (6/119) of the patients were AIEC-positive at both M0 and M6, 43.7% (52/119), patients with history of positive test for AIEC (M0 or M6) had higher risk of ileal endoscopic POR (aOR 2.32 (95% CI 1.01 to 5.39), p=0.048)), i2b-endoscopic postoperative recurrence (aOR 2.41 (95% CI 1.01 to 5.74); p=0.048) and severe endoscopic postoperative (aOR=3.84 (95% CI 1.32 to 11.18), p=0.013). AIEC colonisation was associated with a specific microbiota signature including increased abundance of Ruminococcus gnavus ., Conclusion: Based on the postoperative recurrence model, our data support the idea that AIEC are involved in the early steps of ileal CD., Trial Registration Number: NCT03458195., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2023
- Full Text
- View/download PDF
30. Autologous organoid co-culture model reveals T cell-driven epithelial cell death in Crohn's Disease.
- Author
-
Hammoudi N, Hamoudi S, Bonnereau J, Bottois H, Pérez K, Bezault M, Hassid D, Chardiny V, Grand C, Gergaud B, Bonnet J, Chedouba L, Tran Minh ML, Gornet JM, Baudry C, Corte H, Maggiori L, Toubert A, McBride J, Brochier C, Neighbors M, Le Bourhis L, and Allez M
- Subjects
- Humans, Organoids metabolism, Coculture Techniques, Epithelial Cells metabolism, Crohn Disease metabolism, Inflammatory Bowel Diseases
- Abstract
Lympho-epithelial interactions between intestinal T resident memory cells (Trm) and the epithelium have been associated with inflammatory bowel disease (IBD) activity. We developed ex vivo autologous organoid-mucosal T cell cocultures to functionally assess lymphoepithelial interactions in Crohn's Disease (CD) patients compared to controls. We demonstrate the direct epithelial cell death induced by autologous mucosal T cells in CD patients but not in controls. These findings were positively correlated with T cell infiltration of the organoids. This potential was inhibited by limiting lympho-epithelial interactions through CD103 and NKG2D blocking antibodies. These data directly demonstrate for the first time the direct deleterious effect of mucosal T cells on the epithelium of CD patients. Such ex-vivo models are promising techniques to unravel the pathophysiology of these diseases and the potential mode of action of current and future therapies., Competing Interests: MA received grant supports from Innate Pharma, Janssen, Takeda, Genentech/Roche, and honoraria for teaching activities or consultancy from Abbvie, Amgen, Biogen, Boehringer-Ingelheim, Bristol Myers Squibb, Celgene, Celltrion, Ferring, Genentech, Gilead, IQVIA, Janssen, Novartis, Pfizer, Roche, Takeda, Tillots. NH received honorarium for consultancy from Janssen and Takeda. M-LT-M received honoraria from Abbvie and Janssen. J-MG has been a speaker and/advisory board member for Abbvie, Amgen, Celltrion, Takeda, Janssen and Sanofi Genzyme. SH, JB, HB, KP, LC, MB, VC, BG, CG, DH, JB, HC, LM, CB, AT and LLB have no conflict of interest to declare. MN, JM are employed by Genentech and CB by Institut Roche. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest., (Copyright © 2022 Hammoudi, Hamoudi, Bonnereau, Bottois, Pérez, Bezault, Hassid, Chardiny, Grand, Gergaud, Bonnet, Chedouba, Tran Minh, Gornet, Baudry, Corte, Maggiori, Toubert, McBride, Brochier, Neighbors, Le Bourhis and Allez.)
- Published
- 2022
- Full Text
- View/download PDF
31. Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease.
- Author
-
Ngollo M, Perez K, Hammoudi N, Gorelik Y, Delord M, Auzolle C, Bottois H, Cazals-Hatem D, Bezault M, Nancey S, Nachury M, Treton X, Fumery M, Buisson A, Barnich N, Seksik P, Shen-Orr SS, Le Bourhis L, and Allez M
- Subjects
- Anastomosis, Surgical, Endoscopy, Gastrointestinal, Humans, Ileum surgery, Recurrence, Transcriptome, Crohn Disease drug therapy, Crohn Disease genetics, Crohn Disease surgery
- Abstract
Background and Aims: Ileocolonic resection is frequently needed in the course of Crohn's disease [CD] treatment and post-operative recurrence is extremely common. Our main objective was to analyse gene expression in the mucosa of CD patients at the time of surgery and at post-operative endoscopy, in order to identify predictors and mechanisms of early endoscopic recurrence., Methods: We conducted transcriptome analyses on ileal mucosa samples collected from inflamed sections of the surgical specimens [n = 200], from ileal resection margins [n = 149] and in the neo-terminal ileum 6 months after surgery [n = 122]; these were compared with non-inflammatory bowel disease controls [n = 25]. The primary endpoint was post-operative endoscopic recurrence at 6 months. We applied regression models to identify gene signatures predicting endoscopic recurrence., Results: Chronic inflammation was associated with strong expression of inflammatory genes [IL-6, IL-8, IL-1B] and decreased expression of genes involved in metabolic processes, but with a high inter-individual heterogeneity. Gene signatures associated with early endoscopic recurrence were mainly characterized by upregulation of TNFα, IFNγ, IL23A and IL17A. Pathway analyses showed that upregulation of mitochondrial dysfunction within the inflamed sections and JAK/STAT at the ileal margin were predictive of post-operative recurrence. A combined model integrating these top pathway signatures improved the prediction of endoscopic recurrence [area under the curve of 0.79]. STAT3 phosphorylation at the surgical ileal margin was associated with severe recurrence at 6 months., Conclusion: We identified several biological pathways in surgical ileal mucosa specimens associated with an increased risk of disease recurrence. Integration of the JAK/STAT and mitochondrial dysfunction pathways in the clinical model improved the prediction of post-operative recurrence., (© The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
32. Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases.
- Author
-
Perez K, Ngollo M, Rabinowitz K, Hammoudi N, Seksik P, Xavier RJ, Daly MJ, Dotan I, Le Bourhis L, and Allez M
- Subjects
- Biomarkers metabolism, Humans, Ileum pathology, Inflammation pathology, Transcriptome, Colitis, Ulcerative pathology, Crohn Disease pathology, Inflammatory Bowel Diseases pathology, Pouchitis pathology
- Abstract
Background: Inflammatory bowel diseases (IBDs) are characterized by chronic inflammation and tissue damages in limited segments of the digestive tract. Pathogenesis in the tissue and mucosal inflammation probably differs according to disease location. Our aim was to further analyze transcriptomic profiles in different locations of IBD, differentiating ulcerative colitis (UC), colonic Crohn's disease (CD), ileal CD, and pouchitis, with respect to normal colonic and ileal mucosa. We thus performed a meta-analysis focusing on specific transcriptomic signatures of ileal and colonic diseases., Methods: We identified 5 cohorts with available transcriptomic data in ileal or colonic samples from active IBD and non-IBD control samples. The meta-analysis was performed on 1047 samples. In each cohort separately, we compared gene expression in CD ileitis and normal ileum; in CD colitis, UC, and normal colon; and finally in pouchitis and normal ileum., Results: We identified specific markers of ileal (FOLH1, CA2) and colonic (REG3A) inflammation and showed that, with disease, some cells from the ileum start to express colonic markers. We confirmed by immunohistochemistry that these markers were specifically present in ileal or colonic diseases. We highlighted that, overall, colonic CD resembles UC and is distinct from ileal CD, which is in turn closer to pouchitis., Conclusions: We demonstrated that ileal and colonic diseases exhibit specific signatures, independent of their initial clinical classification. This supports molecular, rather than clinical, disease stratification, and may be used to design drugs specifically targeting ileal or colonic diseases., (© 2021 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
33. Corrigendum to: Meta-Analysis of IBD Gut Samples Gene Expression Identifies Specific Markers of Ileal and Colonic Diseases.
- Author
-
Perez K, Ngollo M, Rabinowitz K, Hammoudi N, Seksik P, Xavier RJ, Daly MJ, Dotan I, Le Bourhis L, and Allez M
- Published
- 2022
- Full Text
- View/download PDF
34. Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn's disease patients.
- Author
-
Chervy M, Sivignon A, Dambrine F, Buisson A, Sauvanet P, Godfraind C, Allez M, Le Bourhis L, The Remind Group, Barnich N, and Denizot J
- Subjects
- Carcinoembryonic Antigen, Enterobacteriaceae, Epigenesis, Genetic, Histone Acetyltransferases genetics, Histone Deacetylase 1, Histone Deacetylases, Humans, Mucous Membrane, Serum Albumin, Bovine, Vorinostat, Crohn Disease, Gastrointestinal Microbiome
- Abstract
Abbreviations: AIEC Adherent-Invasive Escherichia coli ; BSA Bovine serum albumin; CD Crohn's disease; CEABAC10 Carcinoembryonic antigen bacterial artificial chromosome 10; CEACAM Carcinoembryonic antigen-related cell adhesion molecule; FBS Fetal bovine serum; IBD Inflammatory Bowel Disease; HAT Histone acetyltransferase; HDAC Histone deacetylase; kDa KiloDalton; SAHA Suberoylanilide Hydroxamic Acid; Scr Scramble.
- Published
- 2022
- Full Text
- View/download PDF
35. Postoperative Endoscopic Recurrence on the Neoterminal Ileum But Not on the Anastomosis Is Mainly Driving Long-Term Outcomes in Crohn's Disease.
- Author
-
Hammoudi N, Auzolle C, Tran Minh ML, Boschetti G, Bezault M, Buisson A, Pariente B, Treton X, Seksik P, Fumery M, Le Bourhis L, Nancey S, and Allez M
- Subjects
- Adult, Anastomosis, Surgical, Colonoscopy, Disease Progression, Female, Humans, Male, Prospective Studies, Recurrence, Crohn Disease surgery, Ileal Diseases surgery, Postoperative Complications diagnosis
- Abstract
Introduction: Early ileocolonoscopy within the first year after surgery is the gold standard to evaluate recurrence after ileocolonic resection for Crohn's disease (CD). The aim of the study was to evaluate the association between the presence and severity of anastomotic and ileal lesions at early postoperative ileocolonoscopy and long-term outcomes., Methods: The REMIND group conducted a prospective multicenter study. Patients operated for ileal or ileocolonic CD were included. An ileocolonoscopy was performed 6 months after surgery. An endoscopic score describing separately the anastomotic and ileal lesions was built. Clinical relapse was defined by the CD-related symptoms, confirmed by imaging, endoscopy or therapeutic intensification; CD-related complications; or subsequent surgery., Results: Among 225 included patients, long-term follow-up was available in 193 (median follow-up: 3.82 years [interquartile range: 2.56-5.41]). Median clinical recurrence-free survival was 47.6 months. Clinical recurrence-free survival was significantly shorter in patients with ileal lesions at early postoperative endoscopy whatever their severity was (I(1) or I(2,3,4)) as compared to patients without ileal lesions (I(0)) (I(0) vs I(2,3,4): P = 0.0003; I(0) vs I(1): P = 0.0008 and I(1) vs I(2,3,4): P = 0.43). Patients with exclusively ileal lesions (A(0)I(1,2,3,4)) had poorer clinical long-term outcomes than patients with exclusively anastomotic lesions (A(1,2,3)I(0)) (P = 0.009)., Discussion: A score describing separately the anastomotic and ileal lesions might be more appropriate to define postoperative endoscopic recurrence. Our data suggest that patients with ileal lesions, including mild ones (I(1)), could beneficiate from treatment step-up to improve long-term outcomes.
- Published
- 2020
- Full Text
- View/download PDF
36. KLRG1 and CD103 Expressions Define Distinct Intestinal Tissue-Resident Memory CD8 T Cell Subsets Modulated in Crohn's Disease.
- Author
-
Bottois H, Ngollo M, Hammoudi N, Courau T, Bonnereau J, Chardiny V, Grand C, Gergaud B, Allez M, and Le Bourhis L
- Subjects
- CD8-Positive T-Lymphocytes classification, Clinical Trials as Topic, Crohn Disease physiopathology, Gene Expression Profiling, Humans, Immunity, Innate, Inflammation, Interleukins immunology, T-Lymphocyte Subsets immunology, Antigens, CD metabolism, CD8-Positive T-Lymphocytes immunology, Crohn Disease immunology, Immunologic Memory, Integrin alpha Chains metabolism, Intestinal Mucosa immunology, Lectins, C-Type metabolism, Receptors, Immunologic metabolism
- Abstract
Intestinal tissue-resident memory CD8 T cells (Trm) are non-recirculating effector cells ideally positioned to detect and react to microbial infections in the gut mucosa. There is an emerging understanding of Trm cell differentiation and functions, but their implication in inflammatory bowel diseases, such as Crohn's disease (CD), is still unknown. Here, we describe CD8 cells in the human intestine expressing KLRG1 or CD103, two receptors of E-cadherin. While CD103 CD8 T cells are present in high numbers in the mucosa of CD patients and controls, KLRG1 CD8 T cells are increased in inflammatory conditions. Mucosal CD103 CD8 T cells are more responsive to TCR restimulation, but KLRG1 CD8 T cells show increased cytotoxic and proliferative potential. CD103 CD8 T cells originate mostly from KLRG1 negative cells after TCR triggering and TGFβ stimulation. Interestingly, mucosal CD103 CD8 T cells from CD patients display major changes in their transcriptomic landscape compared to controls. They express Th17 related genes including CCL20, IL22, and IL26, which could contribute to the pathogenesis of CD. Overall, these findings suggest that CD103 CD8 T cells in CD induce a tissue-wide alert increasing innate immune responses and recruitment of effector cells such as KLRG1 CD8 T cells., (Copyright © 2020 Bottois, Ngollo, Hammoudi, Courau, Bonnereau, Chardiny, Grand, Gergaud, Allez and Le Bourhis.)
- Published
- 2020
- Full Text
- View/download PDF
37. Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease.
- Author
-
Sokol H, Brot L, Stefanescu C, Auzolle C, Barnich N, Buisson A, Fumery M, Pariente B, Le Bourhis L, Treton X, Nancey S, Allez M, and Seksik P
- Subjects
- Adult, Crohn Disease surgery, Endoscopy, Gastrointestinal, Female, Firmicutes, Humans, Male, Middle Aged, Postoperative Period, Prospective Studies, Proteobacteria, Recurrence, Risk Factors, Young Adult, Crohn Disease diagnostic imaging, Crohn Disease microbiology, Gastrointestinal Microbiome, Ileum microbiology, Intestinal Mucosa microbiology
- Abstract
Objective: Following ileal resection for Crohn's disease (CD), recurrence is very frequent. Although several clinical risk factors of recurrence have been identified, predicting relapse remains challenging. Performing an ileocolonoscopy within the first year after surgery is currently recommended to assess endoscopic recurrence and to adjust the treatment. We took advantage of a large prospective multicentric cohort to investigate the role of the ileal mucosa-associated microbiota in postoperative endoscopic recurrence., Patients and Methods: Ileal mucosa-associated microbiota was analysed by 16S sequencing at the time of surgery and/or of endoscopic evaluation in 201 patients (288 samples in total) prospectively recruited in France., Results: Ileal mucosa-associated microbiota exhibits profound changes following surgery in CD. Compared with non-recurrence setting, endoscopic recurrence is associated with strong changes in ileal mucosa-associated microbiota that are highly reminiscent of those observed generally in ileal CD compared with healthy subjects with a reduction in alpha diversity, an increase in several members of the Proteobacteria phylum and a decrease in several members of the Lachnospiraceae and the Ruminococcaceae families within the Firmicutes phylum. At the time of surgery, we identified several bacterial taxa associated with endoscopic recurrence and that can better predict relapse than usual clinical risk factors., Conclusion: Surgery has an important impact on ileal mucosa-associated microbiota. Postoperative endoscopic recurrence is associated with changes in microbiota composition and alpha diversity. The gut microbiota has the potential to predict postoperative evolution and recurrence., Competing Interests: Competing interests: MA received honoraria from Abbvie, MSD, Janssen, Takeda, Pfizer, Novartis, Ferring, Tillots, Celgene and Genentech/Roche. CA, NB, LLB and CS declares no competing interest. SN received honoraria from MSD, Abbvie, Takeda, Janssen, HAC Pharma, Tillots, Ferring and Novartis. AB received honoraria from MSD, Abbvie, Ferring, Takeda, Vifor Pharma, Sanofi‐Aventis, Hospira and Janssen. BP received honoraria from AbbVie, MSD, Takeda, Janssen, Bioagaran and Ferring. MF received honoraria from AbbVie, MSD, Takeda, Janssen, Pfizer, Ferring and Boehringer. HS received unrestricted study grants from Danone, Biocodex and Enterome; was a board member and a consultant, or received lecture fees from Carenity, Abbvie, Astellas, Danone, Ferring, Mayoly Spindler, MSD, Novartis, Roche, Tillots, Enterome, Maat, BiomX, Biose, Novartis and Takeda; and was cofunder of Nextbiotix. XT received honoraria from Abbvie, MSD, Takeda, Ferring, Norgine and Janssen. PS received honoraria from Takeda, MSD, Biocodex, Ferring and Abbvie, and non-financial support from Takeda., (© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
38. Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's Disease.
- Author
-
Hammoudi N, Cazals-Hatem D, Auzolle C, Gardair C, Ngollo M, Bottois H, Nancey S, Pariente B, Buisson A, Treton X, Fumery M, Bezault M, Seksik P, Le Bourhis L, Flejou JF, and Allez M
- Subjects
- Adult, Anastomosis, Surgical adverse effects, Colectomy adverse effects, Colectomy methods, Digestive System Surgical Procedures adverse effects, Female, Humans, Male, Middle Aged, Prospective Studies, Recurrence, Crohn Disease pathology, Crohn Disease surgery, Digestive System Surgical Procedures methods, Ileum pathology, Ileum surgery, Margins of Excision
- Abstract
Background and Aims: Different types of histologic lesions at the ileal margin, detected by histology, have been associated with increased rates of recurrence after ileocaecal surgery in patients with Crohn's disease (CD). We aimed to characterize histologic features of the ileal margin and to evaluate their association with disease recurrence., Methods: We collected histologic data from 211 patients with ileal or ileocolonic CD who underwent ileocolonic resections at hospitals in France from September 2010 through December 2016. Ileal margins were analyzed. Early endoscopic recurrence was defined by a Rutgeerts score of i2 or more, 6 months after surgery. We also collected data from 10 adults with healthy ileum who underwent ileocecal resection for colonic tumors (controls). Clinical relapse was defined by CD-related symptoms confirmed by imaging, endoscopy, therapy intensification, CD-related complication, or subsequent surgery., Results: Six months after surgery, 49% of patients had endoscopic recurrence; 5 years after surgery, 57% of patients had clinical relapse. Ileal margins were macroscopically affected in 20.9% of patients. CD transmural lesions at the margin (defined by mucosal ulceration or cryptitis, submucosal fibrosis and lymphoplasmacytic infiltrate of the subserosa) were observed in 13.6% of patients. Endoscopic recurrence was observed in 75% of patients with CD transmural lesions vs 46% of patients without (P =.005). In multivariate analysis, CD transmural lesions at the margin were independently associated with early endoscopic recurrence (OR, 3.83; 95% CI, 1.47-11.05; P =.008) and clinical recurrence (OR 2.04; 95% CI, 1.09-3.99; P =.026)., Conclusion: In patients with CD, transmural lesions at the ileal margin were associated with an increased risk of post-operative recurrence. Histologic features of the ileal margin should be included in making decisions about post-operative therapy., (Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
39. T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence.
- Author
-
Allez M, Auzolle C, Ngollo M, Bottois H, Chardiny V, Corraliza AM, Salas A, Perez K, Stefanescu C, Nancey S, Buisson A, Pariente B, Fumery M, Sokol H, Tréton X, Barnich N, Seksik P, and Le Bourhis L
- Subjects
- Adult, Aged, Cohort Studies, Crohn Disease pathology, Female, Humans, Ileitis pathology, Intestinal Mucosa metabolism, Intestinal Mucosa pathology, Male, Middle Aged, Postoperative Period, Recurrence, Treatment Outcome, Young Adult, Crohn Disease etiology, Crohn Disease surgery, Ileitis etiology, Ileitis surgery, Receptors, Antigen, T-Cell metabolism, Smoking
- Abstract
T cell clonal expansions are present in the inflamed mucosa of patients with Crohn's disease (CD) and may be implicated in postoperative recurrence after ileocolonic resection., Methods: T cell receptor (TCR) analysis was performed in 57 patients included in a prospective multicentre cohort. Endoscopic recurrence was defined by a Rutgeerts score >i0. DNA and mRNA were extracted from biopsies collected from the surgical specimen and endoscopy, and analysed by high throughput sequencing and microarray, respectively., Results: TCR repertoire in the mucosa of patients with CD displayed diverse clonal expansions. Active smokers at time of surgery had a significantly increased proportion of clonal expansions as compared with non-smokers (25.9%vs17.9%, p=0.02). The percentage of high frequency clones in the surgical specimen was significantly higher in patients with recurrence and correlated with postoperative endoscopic recurrence (area under the curve (AUC) 0.69, 95% CI 0.54 to 0.83). All patients with clonality above 26.8% (18/57) had an endoscopic recurrence. These patients with a high clonality were more frequently smokers than patients with a low clonality (61% vs 23%, p=0.005). The persistence of a similar TCR repertoire at postoperative endoscopy was associated with smoking and disease recurrence. Patients with high clonality showed increased expression of genes associated with CD8 T cells and reduced expression of inflammation-related genes. Expanded clones were found predominantly in the CD8 T cell compartment., Conclusion: Clonal T cell expansions are implicated in postoperative endoscopic recurrence. CD patients with increased proportion of clonal T cell expansions in the ileal mucosa represent a subgroup associated with smoking and where pathogenesis appears as T cell driven., Trial Registration Number: NCT03458195., Competing Interests: Competing interests: MA received honoraria from Abbvie, MSD, Janssen, Takeda, Pfizer, Novartis, Ferring, Tillots, Celgene and Genentech/Roche. SN received honoraria from MSD, Abbvie, Takeda, Janssen, HAC Pharma, Tillots, Ferring and Novartis. AB received honoraria from MSD, Abbvie, Ferring, Takeda, Vifor Pharma, Sanofi‐Aventis, Hospira and Janssen. BP received honoraria from AbbVie, MSD, Takeda, Janssen, Bioagaran and Ferring. MF received honoraria from AbbVie, MSD, Takeda, Janssen, Pfizer, Ferring and Boehringer. HS received unrestricted study grants: Danone, Biocodex and Enterome; board membership, consultancy, or lecture fees: Carenity, Abbvie, Astellas, Danone, Ferring, Mayoly Spindler, MSD, Novartis, Roche, Tillots, Enterome, Maat, BiomX, Biose, Novartis and Takeda; cofunder of Nextbiotix. XT received honoraria from Abbvie, MSD, Takeda, Ferring, Norgine and Janssen. PS received honoraria from Takeda, MSD, Biocodex, Ferring and Abbvie, and non-financial support from Takeda. CA, MN, HB, VC, AMC, AS, CS and NB declare no competing interest., (© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2019
- Full Text
- View/download PDF
40. Differences in Peripheral and Tissue Immune Cell Populations Following Haematopoietic Stem Cell Transplantation in Crohn's Disease Patients.
- Author
-
Corraliza AM, Ricart E, López-García A, Carme Masamunt M, Veny M, Esteller M, Mayorgas A, Le Bourhis L, Allez M, Planell N, Visvanathan S, Baum P, España C, Cabezón-Cabello R, Benítez-Ribas D, Rovira M, Panés J, and Salas A
- Subjects
- Adult, B-Lymphocytes, Crohn Disease immunology, Female, Humans, Macrophages, Male, Neutrophils, T-Lymphocytes, Treatment Outcome, Crohn Disease therapy, Hematopoietic Stem Cell Transplantation, Lymphocyte Count
- Abstract
Background and Aims: Recent studies have shown the efficacy of autologous haematopoietic stem cell transplantation [HSCT] in severely refractory Crohn's disease [CD] patients. HSCT is thought to eliminate auto-reactive cells; however, no specific studies of immune reconstitution in CD patients are available., Methods: We followed a group of CD patients [n = 18] receiving autologous HSCT, with 50% of them achieving endoscopic drug-free remission. To elucidate the mechanisms driving efficacy, we monitored changes after HSCT in blood and intestine immune-cell composition. CD patients [n = 22] receiving anti-tumour necrosis factor [TNF]-α were included for comparison., Results: Severe immune ablation followed by HSCT induced dramatic changes in both peripheral blood T and B cells in all patients regardless of the efficacy of the treatment. Endoscopic remission at week 52 following HSCT was associated with significant intestinal transcriptional changes. A comparison of the remission signature with that of anti-TNFα identified both common and unique genes in the HSCT-induced response. Based on deconvolution analysis of intestinal biopsy transcriptome data, we show that response to HSCT, but not to anti-TNFα, is associated with an expansion of naïve B-cells, as seen in blood, and a decrease in the memory resting T-cell content. As expected, endoscopic remission, in response to both HSCT and anti-TNFα, led to a significant reduction in intestinal neutrophil and M1 macrophage content., Conclusions: Peripheral blood immune remodelling after HSCT does not predict efficacy. In contrast, a profound intestinal T-cell depletion that is maintained long after transplant is associated with mucosal healing following HSCT, but not anti-TNFα., (© European Crohn’s and Colitis Organisation (ECCO) 2018.)
- Published
- 2019
- Full Text
- View/download PDF
41. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
- Author
-
Courau T, Bonnereau J, Chicoteau J, Bottois H, Remark R, Assante Miranda L, Toubert A, Blery M, Aparicio T, Allez M, and Le Bourhis L
- Subjects
- Cell Line, Tumor, Cell Proliferation drug effects, Cell Survival drug effects, Coculture Techniques, Colorectal Neoplasms drug therapy, HT29 Cells, Humans, Killer Cells, Natural immunology, Molecular Targeted Therapy, Spheroids, Cellular drug effects, Spheroids, Cellular metabolism, T-Lymphocytes immunology, Antineoplastic Agents, Immunological pharmacology, Colorectal Neoplasms immunology, Histocompatibility Antigens Class I metabolism, NK Cell Lectin-Like Receptor Subfamily C metabolism, Spheroids, Cellular cytology
- Abstract
Background: Immunotherapies still fail to benefit colorectal cancer (CRC) patients. Relevant functional assays aimed at studying these failures and the efficacy of cancer immunotherapy in human are scarce. 3D tumor cultures, called tumor organoids or spheroids, represent interesting models to study cancer treatments and could help to challenge these issues., Methods: We analyzed heterotypic cocultures of human colon tumor-derived spheroids with immune cells to assess the infiltration, activation and function of T and NK cells toward human colorectal tumors in vitro., Results: We showed that allogeneic T and NK cells rapidly infiltrated cell line-derived spheroids, inducing immune-mediated tumor cell apoptosis and spheroid destruction. NKG2D, a key activator of cytotoxic responses, was engaged on infiltrating cells. We thus assessed the therapeutic potential of an antibody targeting the specific ligands of NKG2D, MICA and MICB, in this system. Anti-MICA/B enhanced immune-dependent destruction of tumor spheroid by driving an increased NK cells infiltration and activation. Interestingly, tumor cells reacted to immune infiltration by upregulating HLA-E, ligand of the inhibitory receptor NKG2A expressed by CD8 and NK cells. NKG2A was increased after anti-MICA/B treatment and, accordingly, combination of anti-MICA/B and anti-NKG2A was synergistic. These observations were ultimately confirmed in a clinical relevant model of coculture between CRC patients-derived spheroids and autologous tumor-infiltrating lymphocytes., Conclusions: Altogether, we show that tumor spheroids represent a relevant tool to study tumor-lymphocyte interactions on human tissues and revealed the antitumor potential of immunomodulatory antibodies targeting MICA/B and NKG2A.
- Published
- 2019
- Full Text
- View/download PDF
42. Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation.
- Author
-
Parlato M, Charbit-Henrion F, Abi Nader E, Begue B, Guegan N, Bruneau J, Khater S, Macintyre E, Picard C, Frédéric RL, Le Bourhis L, Allez M, Goulet O, Cellier C, Hermine O, Cerf-Bensussan N, and Malamut G
- Subjects
- Chronic Disease, Diarrhea etiology, Enterocolitis complications, Female, Gain of Function Mutation, Humans, Nitriles, Pyrimidines, Exome Sequencing, Young Adult, Enterocolitis drug therapy, Enterocolitis genetics, Protein Kinase Inhibitors therapeutic use, Pyrazoles therapeutic use, STAT3 Transcription Factor genetics
- Published
- 2019
- Full Text
- View/download PDF
43. Editorial: predicting recurrence of Crohn's disease after surgical resection-Close to a crystal ball. Authors' reply.
- Author
-
Allez M, Auzolle C, Le Bourhis L, and Seksik P
- Subjects
- Humans, Male, Prospective Studies, Recurrence, Risk Factors, Smoking, Crohn Disease surgery
- Published
- 2018
- Full Text
- View/download PDF
44. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation.
- Author
-
Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, Serafini N, Puel A, Bustamante J, Surace L, Masse-Ranson G, David E, Strick-Marchand H, Le Bourhis L, Cocchi R, Topazio D, Graziano P, Muscarella LA, Rogge L, Norel X, Sallenave JM, Allez M, Graf T, Hendriks RW, Casanova JL, Amit I, Yssel H, and Di Santo JP
- Subjects
- Animals, Antigens, CD34 analysis, Cell Differentiation, Cell Lineage, Fetal Blood cytology, Fetus cytology, Humans, Immunity, Innate, Interleukin-17, Liver cytology, Lung cytology, Lymphocytes immunology, Lymphoid Tissue cytology, Mice, Proto-Oncogene Proteins c-kit analysis, Transcription, Genetic, Lymphocytes cytology, Stem Cells cytology
- Abstract
Innate lymphoid cells (ILCs) represent innate versions of T helper and cytotoxic T cells that differentiate from committed ILC precursors (ILCPs). How ILCPs give rise to mature tissue-resident ILCs remains unclear. Here, we identify circulating and tissue ILCPs in humans that fail to express the transcription factors and cytokine outputs of mature ILCs but have these signature loci in an epigenetically poised configuration. Human ILCPs robustly generate all ILC subsets in vitro and in vivo. While human ILCPs express low levels of retinoic acid receptor (RAR)-related orphan receptor C (RORC) transcripts, these cells are found in RORC-deficient patients and retain potential for EOMES
+ natural killer (NK) cells, interferon gamma-positive (IFN-γ+ ) ILC1s, interleukin (IL)-13+ ILC2s, and for IL-22+ , but not for IL-17A+ ILC3s. Our results support a model of tissue ILC differentiation ("ILC-poiesis"), whereby diverse ILC subsets are generated in situ from systemically distributed ILCPs in response to local environmental signals., (Copyright © 2017 Elsevier Inc. All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
45. IL-12 drives functional plasticity of human group 2 innate lymphoid cells.
- Author
-
Lim AI, Menegatti S, Bustamante J, Le Bourhis L, Allez M, Rogge L, Casanova JL, Yssel H, and Di Santo JP
- Subjects
- Animals, Cells, Cultured, Crohn Disease pathology, Female, Humans, Interferon-gamma immunology, Interleukin-13 immunology, Interleukin-5 immunology, Intestines pathology, Lymphocytes pathology, Male, Mice, Crohn Disease immunology, Immunity, Innate, Interleukin-12 immunology, Intestines immunology, Lymphocytes immunology
- Abstract
Group 2 innate lymphoid cells (ILC2) include IL-5- and IL-13-producing CRTh2(+)CD127(+)cells that are implicated in early protective immunity at mucosal surfaces. Whereas functional plasticity has been demonstrated for both human and mouse ILC3 subsets that can reversibly give rise to IFN-γ-producing ILC1, plasticity of human or mouse ILC2 has not been shown. Here, we analyze the phenotypic and functional heterogeneity of human peripheral blood ILC2. Although subsets of human CRTh2(+)ILC2 differentially express CD117 (c-kit receptor), some ILC2 surface phenotypes are unstable and can be modulated in vitro. Surprisingly, human IL-13(+)ILC2 can acquire the capacity to produce IFN-γ, thereby generating plastic ILC2. ILC2 cultures demonstrated that IFN-γ(+)ILC2 clones could be derived and were stably associated with increased T-BET expression. The inductive mechanism for ILC2 plasticity was mapped to the IL-12-IL-12R signaling pathway and was confirmed through analysis of patients with Mendelian susceptibility to mycobacterial disease due to IL-12Rβ1 deficiencies that failed to generate plastic ILC2. We also detected IL-13(+)IFN-γ(+)ILC2 ex vivo in intestinal samples from Crohn's disease patients. These results demonstrate cytokine production plasticity for human ILC2 and further suggest that environmental cues can dictate ILC phenotype and function for these tissue-resident innate effector cells., (© 2016 Lim et al.)
- Published
- 2016
- Full Text
- View/download PDF
46. Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation.
- Author
-
Cui Y, Franciszkiewicz K, Mburu YK, Mondot S, Le Bourhis L, Premel V, Martin E, Kachaner A, Duban L, Ingersoll MA, Rabot S, Jaubert J, De Villartay JP, Soudais C, and Lantz O
- Subjects
- Animals, Chemotaxis, Leukocyte, Crosses, Genetic, Disease Models, Animal, Female, Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor, Germ-Free Life, Histocompatibility Antigens Class I immunology, Humans, Immunologic Memory, Kruppel-Like Transcription Factors analysis, Lymphocyte Activation, Lymphocyte Count, Lymphoid Tissue cytology, Lymphokines metabolism, Mice, Mice, Congenic genetics, Mice, Congenic microbiology, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Microbiota, Minor Histocompatibility Antigens, Natural Killer T-Cells metabolism, Nuclear Receptor Subfamily 1, Group F, Member 3 analysis, Phenotype, Polymorphism, Single Nucleotide, Promyelocytic Leukemia Zinc Finger Protein, Radiation Chimera, Receptors, Antigen, T-Cell, alpha-beta genetics, Receptors, Cytokine analysis, Urinary Tract Infections immunology, Urinary Tract Infections microbiology, Mice, Congenic immunology, Natural Killer T-Cells immunology
- Abstract
Mucosal-associated invariant T cells (MAITs) have potent antimicrobial activity and are abundant in humans (5%-10% in blood). Despite strong evolutionary conservation of the invariant TCR-α chain and restricting molecule MR1, this population is rare in laboratory mouse strains (≈0.1% in lymphoid organs), and lack of an appropriate mouse model has hampered the study of MAIT biology. Herein, we show that MAITs are 20 times more frequent in clean wild-derived inbred CAST/EiJ mice than in C57BL/6J mice. Increased MAIT frequency was linked to one CAST genetic trait that mapped to the TCR-α locus and led to higher usage of the distal Vα segments, including Vα19. We generated a MAIThi congenic strain that was then crossed to a transgenic Rorcgt-GFP reporter strain. Using this tool, we characterized polyclonal mouse MAITs as memory (CD44+) CD4-CD8lo/neg T cells with tissue-homing properties (CCR6+CCR7-). Similar to human MAITs, mouse MAITs expressed the cytokine receptors IL-7R, IL-18Rα, and IL-12Rβ and the transcription factors promyelocytic leukemia zinc finger (PLZF) and RAR-related orphan receptor γ (RORγt). Mouse MAITs produced Th1/2/17 cytokines upon TCR stimulation and recognized a bacterial compound in an MR1-dependent manner. During experimental urinary tract infection, MAITs migrated to the bladder and decreased bacterial load. Our study demonstrates that the MAIThi congenic strain allows phenotypic and functional characterization of naturally occurring mouse MAITs in health and disease.
- Published
- 2015
- Full Text
- View/download PDF
47. In Vitro and In Vivo Analysis of the Gram-Negative Bacteria-Derived Riboflavin Precursor Derivatives Activating Mouse MAIT Cells.
- Author
-
Soudais C, Samassa F, Sarkis M, Le Bourhis L, Bessoles S, Blanot D, Hervé M, Schmidt F, Mengin-Lecreulx D, and Lantz O
- Subjects
- Animals, Disease Models, Animal, Escherichia coli immunology, Flow Cytometry, Histocompatibility Antigens Class I immunology, In Vitro Techniques, Ligands, Mice, Mice, Inbred C57BL, Mice, Transgenic, Minor Histocompatibility Antigens, Mucous Membrane immunology, Escherichia coli Infections immunology, Lymphocyte Activation immunology, Natural Killer T-Cells immunology, Riboflavin immunology, Riboflavin metabolism
- Abstract
Mucosal-associated invariant T (MAIT) cells recognize microbial compounds presented by the MHC-related 1 (MR1) protein. Although riboflavin precursor derivatives from Gram-positive bacteria have been characterized, some level of ligand heterogeneity has been suggested through the analysis of the MAIT cell TCR repertoire in humans and differential reactivity of human MAIT cell clones according to the bacteria. In this study, using Gram-negative bacteria mutated for the riboflavin biosynthetic pathway, we show a strict correlation between the ability to synthesize the 5-amino-ribityl-uracil riboflavin precursor and to activate polyclonal and quasi-monoclonal mouse MAIT cells. To our knowledge, we show for the first time that the semipurified bacterial fraction and the synthetic ligand activate murine MAIT cells in vitro and in vivo. We describe new MR1 ligands that do not activate MAIT cells but compete with bacterial and synthetic compounds activating MAIT cells, providing the capacity to modulate MAIT cell activation. Through competition experiments, we show that the most active synthetic MAIT cell ligand displays the same functional avidity for MR1 as does the microbial compound. Altogether, these results show that most, if not all, MAIT cell ligands found in Escherichia coli are related to the riboflavin biosynthetic pathway and display very limited heterogeneity., (Copyright © 2015 by The American Association of Immunologists, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
48. Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status.
- Author
-
Chirica M, Le Bourhis L, Lehmann-Che J, Chardiny V, Bouhidel F, Foulboeuf L, Gornet JM, Lourenco N, Dulphy N, Toubert A, and Allez M
- Abstract
Colorectal cancers (CRC) develop in the face of an important immune system associated with the intestinal mucosal tissue. The immune response against the tumor has been proposed to affect the prognosis of patients undergoing treatment for CRC. In this study T cells infiltrating the tumor were compared with T cells populating the unaffected neighboring mucosal tissue and cells from the peripheral blood. We observed that T cells from the tumor harbor an activated phenotype, with engagement of the NKG2D pathway in CD8 T cells. We show that mucosal and tumor-infiltrating T cells are enriched in NKG2D CD4 T cells, which exhibit cytotoxic functions. Finally, T cell populations in the tumor were modified according to its oncogenetic status, with higher percentages of CD8 T cells isolated from patients with microsatellite instable tumor status.
- Published
- 2015
- Full Text
- View/download PDF
49. Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections.
- Author
-
Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F, Milder M, Louis D, Chiche JD, Mira JP, Lantz O, and Pène F
- Subjects
- Adult, Aged, Aged, 80 and over, Critical Illness, Female, Humans, Intensive Care Units, Killer Cells, Natural immunology, Male, Middle Aged, Mucous Membrane immunology, Prospective Studies, Severity of Illness Index, Bacterial Infections immunology, T-Lymphocytes immunology
- Abstract
Purpose: In between innate and adaptive immunity, the recently identified innate-like mucosal-associated invariant T (MAIT) lymphocytes display specific reactivity to non-streptococcal bacteria. Whether they are involved in bacterial sepsis has not been investigated. We aimed to assess the number and the time course of circulating innate-like T lymphocytes (MAIT, NKT and γδ T cells) in critically ill septic and non-septic patients and to establish correlations with the further development of intensive care unit (ICU)-acquired infections., Methods: We prospectively enrolled consecutive patients with severe sepsis and septic shock. Controls were critically ill patients with non-septic shock and age-matched healthy subjects. Circulating innate-like lymphocytes were enumerated using a flow cytometry assay at day 1, 4 and 7., Results: One hundred and fifty six patients (113 severe bacterial infections, 36 non-infected patients and 7 patients with severe viral infections) and 26 healthy subjects were enrolled into the study. Patients with severe bacterial infections displayed an early decrease in MAIT cell count [median 1.3/mm(3); interquartile range (0.4-3.2)] as compared to control healthy subjects [31.1/mm(3) (12.1-45.2)], but also to non-infected critically ill patients [4.3/mm(3) (1.4-13.2)] (P < 0.0001 for all comparisons). In contrast NKT and γδ T cell counts did not differ between patients groups. The multivariate analysis identified non-streptococcal bacterial infection as an independent determinant of decrease in MAIT cell count. Furthermore, the incidence of ICU-acquired infections was higher in patients with persistent MAIT cell depletion., Conclusions: This large human study provides valuable information about MAIT cells in severe bacterial infections. The persistent depletion of MAIT cells is associated with the further development of ICU-acquired infections.
- Published
- 2014
- Full Text
- View/download PDF
50. Double-positive thymocytes select mucosal-associated invariant T cells.
- Author
-
Seach N, Guerri L, Le Bourhis L, Mburu Y, Cui Y, Bessoles S, Soudais C, and Lantz O
- Subjects
- Animals, Antigen Presentation, Antigens, Bacterial immunology, Antigens, Differentiation, T-Lymphocyte analysis, Cell Lineage, Cells, Cultured, Coculture Techniques, Escherichia coli immunology, Female, Genes, Immunoglobulin, Hematopoietic Stem Cells classification, Hematopoietic Stem Cells cytology, Histocompatibility Antigens Class I genetics, Immunoglobulin Variable Region genetics, Immunologic Deficiency Syndromes genetics, Immunologic Deficiency Syndromes immunology, Lymphocyte Activation, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Minor Histocompatibility Antigens, Natural Killer T-Cells cytology, Natural Killer T-Cells immunology, Organ Culture Techniques, Radiation Chimera, Receptors, Antigen, T-Cell, alpha-beta genetics, Specific Pathogen-Free Organisms, Stromal Cells physiology, T-Lymphocyte Subsets chemistry, Thymus Gland cytology, Thymus Gland immunology, CD4 Antigens analysis, CD8 Antigens analysis, Clonal Selection, Antigen-Mediated, Histocompatibility Antigens Class I immunology, Lymphopoiesis immunology, T-Lymphocyte Subsets immunology
- Abstract
NKT and mucosal-associated invariant T (MAIT) cells express semi-invariant TCR and restriction by nonclassical MHC class Ib molecules. Despite common features, the respective development of NKT and MAIT subsets is distinct. NKTs proliferate extensively and acquire effector properties prior to thymic export. MAIT cells exit the thymus as naive cells and acquire an effector/memory phenotype in a process requiring both commensal flora and B cells. During thymic development, NKTs are selected by CD1d-expressing cortical thymocytes; however, the hematopoietic cell type responsible for MAIT cell selection remains unresolved. Using reaggregated thymic organ culture and bone marrow chimeras, we demonstrate that positive selection of mouse iVα19 transgenic and Vβ6 transgenic MAIT cell progenitors requires MHC-related 1-expressing CD4(+)CD8(+) double positive thymocytes, whereas thymic B cells, macrophages, and dendritic cell subsets are dispensable. Preincubation of double positive thymocytes with exogenous bacterial ligand increases MHC-related 1 surface expression and enhances mature MAIT cell activation in the in vitro cocultures. The revelation of a common cell type for the selection of both NKT and MAIT subsets raises questions about the mechanisms underlying acquisition of their specific features.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.